GAITSTIM: Study of the Improvement of Gait by Spinal Stimulation in Patients With Post-operative Chronic Lumbosciatalgia: Pilot Study (GaitStim)

Sponsor
Centre Hospitalier Universitaire de Nice (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05857696
Collaborator
(none)
36
1
1
32.1
1.1

Study Details

Study Description

Brief Summary

The purpose of this study is to explore the changes in objective walking parameters induced by medullary stimulation in patients with Fail Back Surgery Syndrome, after chronic stimulation, in comparison with preoperative condition.

Condition or Disease Intervention/Treatment Phase
  • Other: walking quantified analysis
N/A

Detailed Description

After the informed consent signature, a first assessment will be carried out, including:

quantified analysis of walking (AQM), felt effort questionnaire, pain questionnaires, functional abilities, limitations, goals and quality of life.

The implantation of the spinal cord stimulation system will be performed in two stages: the first stage, the electrode alone will be implanted and connected to an external test stimulator, allowing a one-week stimulation test.

If the test is positive (EVA pain improvement > or = 50%), the second step will be to connect this electrode to a Spectra WaveWriterâ„¢ internal stimulator. This stimulator delivers three different stimulation modalities: tonic, microburst and high frequency. The activated initial stimulation mode will be the tonic one.

After 3 months of "tonic" stimulation, the patient will be treated successively and in random way by 3 other different stimulation modalities during a week: microburst, high frequency, stopped stimulation (Off). The AQM and the different questionnaires will be done again, which will determine which stimulation modality is most beneficial to the patient.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Prospective study on the evolution of spatial-temporal parameters of walking for each mode of medullary neurostimulation.Prospective study on the evolution of spatial-temporal parameters of walking for each mode of medullary neurostimulation.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Study of the Improvement of Gait by Spinal Stimulation in Patients With Post-operative Chronic Lumbosciatalgia: Pilot Study
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2026
Anticipated Study Completion Date :
Feb 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Other: neurostimulation

3 months of tonic stimutaltion + 3 weeks with random stimulation mode between microburst, High frequency, stopped stimulation (Off) then stimulation with the more efficient mode (according the patient) until 6 monthe after implantation.

Other: walking quantified analysis
Test to measure anthropometry, joint amplitudes, muscle strength and spasticity of the lower limbs on a treadmill.

Outcome Measures

Primary Outcome Measures

  1. To explore the changes in objective walking parameters induced by spinal stimulation in patients with FBSS, after 6 months of chronic stimulation, in comparison with preoperative status. [At baseline, 3 and 6 months after implantation]

    Gait quantified analysis with Gait Deviation Index

Secondary Outcome Measures

  1. To describe the gait alteration in a population of patients with FBSS [At baseline, 3 and 6 months after implantation]

    Gait quantified analysis with Gait Deviation Index

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 year old and < or = 70 year old

  • Patients with chronic neuropathic lumbo-sciatalgia (DN4 score > or = 4/10) as part of a moderate to severe spinal surgery failure syndrome (EVA >50/100), in who a collegial and multidisciplinary indication of medullary stimulation treatment was chosen.

  • Patients awith Social Security

Exclusion Criteria:
  • Vulnerable persons

  • Patients who are invalid and unable to perform a quantified walk analysis

  • Contraindication to surgery or anesthesia

  • Patient not able to complete questionnaires

  • Woman of childbearing age without effective contraception

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu de Nice Nice France 06200

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nice

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT05857696
Other Study ID Numbers:
  • 22-AOI-09
First Posted:
May 12, 2023
Last Update Posted:
May 12, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire de Nice
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 12, 2023